Similar Search Results

Taiwan's pharmaceuticals : a failure of the sectoral system of innovation?

Hu, Mei-chih; Hung, Shih-Chang - In: Technological forecasting & social change : an … 88 (2014), pp. 162-176

Persistent link: https://www.econbiz.de/10010483232

R&D policy, agency costs and innovation in personalized medicine

Yin, Wesley - In: Journal of health economics 28 (2009) 5, pp. 950-962

Persistent link: https://www.econbiz.de/10003917080

Government, policy-making and the development of innovation system : the cases of Taiwanese pharmaceutical biotechnology policies (2000–2008)

Chung, Chao-chen - In: Research policy : policy, management and economic … 42 (2013) 5, pp. 1053-1071

Persistent link: https://www.econbiz.de/10009766322

Research and innovation for drug development in neglected diseases : a case study of India

Bhattacharya, Sujit; Pushkaran, Jayanthi A. - In: African journal of science, technology, innovation & … 3 (2011) 3, pp. 236-258

Persistent link: https://www.econbiz.de/10009731729

How pharmaceutical innovation evolves : the path from science to technological development to marketable drugs

Wang, Xuefeng; Zhang, Shuo; Liu, Yuqin; Du, Jian; … - In: Technological forecasting & social change : an … 167 (2021), pp. 1-12

Persistent link: https://www.econbiz.de/10012801454

COVID-19 vaccine development in a Quadruple Helix innovation system : uncovering the preferences of the fourth helix in the UAE

Niankara, Ibrahim; Muqattash, Riham Suleiman; Niankara, … - In: Journal of open innovation : technology, market, and … 6 (2020) 4/132, pp. 1-25

Successful development and uptake of vaccine technology in a Quadruple Helix Innovative health or economic system requires a clear understanding of society's preferences as the fourth helix. With significant financial commitments to find a safe and effective COVID-19 vaccine still ongoing, this...

Persistent link: https://www.econbiz.de/10012315335